Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1990 1
1991 1
1992 1
1994 1
1995 5
1996 1
1997 1
1998 5
1999 4
2000 3
2001 3
2002 3
2003 1
2004 9
2005 7
2006 12
2007 12
2008 11
2009 7
2010 6
2011 13
2012 9
2013 14
2014 14
2015 12
2016 11
2017 13
2018 15
2019 13
2020 32
2021 23
2022 15
2023 21
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
New directions in the treatment of opioid withdrawal.
Srivastava AB, Mariani JJ, Levin FR. Srivastava AB, et al. Among authors: levin fr. Lancet. 2020 Jun 20;395(10241):1938-1948. doi: 10.1016/S0140-6736(20)30852-7. Lancet. 2020. PMID: 32563380 Free PMC article. Review.
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
HEALing Communities Study Consortium; Samet JH, El-Bassel N, Winhusen TJ, Jackson RD, Oga EA, Chandler RK, Villani J, Freisthler B, Adams J, Aldridge A, Angerame A, Babineau DC, Bagley SM, Baker TJ, Balvanz P, Barbosa C, Barocas J, Battaglia TA, Beard DD, Beers D, Blevins D, Bove N, Bridden C, Brown JL, Bush HM, Bush JL, Caldwell R, Calver K, Calvert D, Campbell ANC, Carpenter J, Caspar R, Chassler D, Chaya J, Cheng DM, Cunningham CO, Dasgupta A, David JL, Davis A, Dean T, Drainoni ML, Eggleston B, Fanucchi LC, Feaster DJ, Fernandez S, Figueroa W, Freedman DA, Freeman PR, Freiermuth CE, Friedlander E, Gelberg KH, Gibson EB, Gilbert L, Glasgow L, Goddard-Eckrich DA, Gomori S, Gruss DE, Gulley J, Gutnick D, Hall ME, Harger Dykes N, Hargrove SL, Harlow K, Harris A, Harris D, Helme DW, Holloway J, Hotchkiss J, Huang T, Huerta TR, Hunt T, Hyder A, Ingram VL, Ingram T, Kauffman E, Kimball JL, Kinnard EN, Knott C, Knudsen HK, Konstan MW, Kosakowski S, Larochelle MR, Leaver HM, LeBaron PA, Lefebvre RC, Levin FR, Lewis N, Lewis N, Lofwall MR, Lounsbury DW, Luster JE, Lyons MS, Mack A, Marks KR, Marquesano S, Mauk R, McAlearney AS, McConnell K, McGladrey ML, McMullan J, Miles J, Muno… See abstract for full author list ➔ HEALing Communities Study Consortium, et al. Among authors: levin fr. N Engl J Med. 2024 Sep 19;391(11):989-1001. doi: 10.1056/NEJMoa2401177. Epub 2024 Jun 16. N Engl J Med. 2024. PMID: 38884347 Clinical Trial.
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A; ICASA consensus group; Matthys F. Crunelle CL, et al. Among authors: levin fr. Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6. Eur Addict Res. 2018. PMID: 29510390 Free PMC article.
Beth Macy's Dopesick.
Williams AR, Levin FR. Williams AR, et al. Among authors: levin fr. Cerebrum. 2018 Nov 1;2018:cer-15-18. eCollection 2018 Nov-Dec. Cerebrum. 2018. PMID: 30746023 Free PMC article.
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.
Kiluk BD, Kleykamp BA, Comer SD, Griffiths RR, Huhn AS, Johnson MW, Kampman KM, Pravetoni M, Preston KL, Vandrey R, Bergeria CL, Bogenschutz MP, Brown RT, Dunn KE, Dworkin RH, Finan PH, Hendricks PS, Houtsmuller EJ, Kosten TR, Lee DC, Levin FR, McRae-Clark A, Raison CL, Rasmussen K, Turk DC, Weiss RD, Strain EC. Kiluk BD, et al. Among authors: levin fr. JAMA Psychiatry. 2023 Jan 1;80(1):84-92. doi: 10.1001/jamapsychiatry.2022.4020. JAMA Psychiatry. 2023. PMID: 36449315 Free PMC article. Review.
Herbert D. Kleber.
Levin FR, Lieberman JA, Pardes H. Levin FR, et al. Neuropsychopharmacology. 2019 Apr;44(5):1007. doi: 10.1038/s41386-019-0318-7. Epub 2019 Feb 4. Neuropsychopharmacology. 2019. PMID: 30718705 Free PMC article. No abstract available.
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials.
Haney M, Vallée M, Fabre S, Collins Reed S, Zanese M, Campistron G, Arout CA, Foltin RW, Cooper ZD, Kearney-Ramos T, Metna M, Justinova Z, Schindler C, Hebert-Chatelain E, Bellocchio L, Cathala A, Bari A, Serrat R, Finlay DB, Caraci F, Redon B, Martín-García E, Busquets-Garcia A, Matias I, Levin FR, Felpin FX, Simon N, Cota D, Spampinato U, Maldonado R, Shaham Y, Glass M, Thomsen LL, Mengel H, Marsicano G, Monlezun S, Revest JM, Piazza PV. Haney M, et al. Among authors: levin fr. Nat Med. 2023 Jun;29(6):1487-1499. doi: 10.1038/s41591-023-02381-w. Epub 2023 Jun 8. Nat Med. 2023. PMID: 37291212 Free PMC article. Clinical Trial.
272 results